Gemcitabine treatment in cutaneous T-cell lymphoma: a multicentre study of 23 cases

Abstract

Our study confirms the early efficacy of gemcitabine in advanced-stage CTCL. However, our results contradict the safety profile of gemcitabine previously reported and underline the high incidence of severe complications including visceral and cutaneous involvement.